The GSE10950 dataset showed that CDKN2A and CMTM8 mRNA expression levels were up-regulated in colon cancer samples, while ILK was considerably down-regulated in colon cancer samples (Fig. 3A). This evidence concerns the gene CDKN2A and colonic neoplasm.